Status: Not yet recruiting
Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
The aim of this clinical trial is to determine whether Lymphaticovenous Anastomosis can treat Alzheimer's disease，in AD patients aged 18-80.he main questions it aims to answer are: 1. Can Lymphaticovenous Anastomosis improve cognitive function, daily living ability, mood, or sleep status in patients with Alzheimer's dementia, demonstrating good therapeutic efficacy? 2. Does deep Lymphaticovenous Anastomosis lead to changes in peripheral blood biomarker levels, neuroinflammatory responses, and neuroimaging in patients with Alzheimer's dementia?
Participants needed: 20
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Luo XinxinUpdated: Nov 27, 2024Locations: 1
Eligibility criteria
At least two deputy chief physicians or above, diagnosed with Alzheimer's dement... [+5]
Individuals with contraindications for Lymphaticovenous Anastomosis; those aller... [+5]